Official record
Measure details
- Jurisdiction
- Washington
- Session
- 2025-2026
- Chamber
- upper
- Classification
- bill
- Subjects
- Not supplied
- Introduced / first action
- 2025-01-14 00:00:00
Washington 2025-2026
Concerning anaphylaxis medications in schools.
Official record
Source-supplied history
By resolution, returned to Senate Rules Committee for third reading.
Rules Committee relieved of further consideration. Placed on second reading.
reading-2Referred to Rules 2 Review.
referral-committeeED - Majority; do pass with amendment(s).
committee-passage-favorableExecutive action taken in the House Committee on Education at 1:30 PM.
Public hearing in the House Committee on Education at 10:30 AM.
First reading, referred to Education.
reading-1, referral-committeeThird reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
reading-3Placed on third reading by Rules Committee.
reading-3By resolution, reintroduced and retained in present status.
By resolution, returned to Senate Rules Committee for third reading.
Public hearing in the House Committee on Education at 4:00 PM.
First reading, referred to Education.
reading-1, referral-committeeThird reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
reading-3Rules suspended. Placed on Third Reading.
reading-31st substitute bill substituted (EDU 25).
substitutionPlaced on second reading by Rules Committee.
reading-2Passed to Rules Committee for second reading.
EDU - Majority; 1st substitute bill be substituted, do pass.
substitutionExecutive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM.
Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM.
First reading, referred to Early Learning & K-12 Education.
reading-1, referral-committeeDocuments and versions
Recorded votes
When supplied by the API
No resolvable related measure is supplied.
Traceable provenance
Provider updated: 2026-10-28 10:42:47. Locally fetched: 2026-11-04 03:30:03.